Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

NCT00843349 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: Lanthanum Carbonate
OTHER: 900 mg Phosphate Diet
DRUG: LC Placebo
OTHER: Ad Libitum Diet

Sponsor

Myles Wolf

Collaborators

[object Object]
[object Object]